Aldose Reductase: Zenerstat

Entry criteria (2/3): symptoms, signs, abnormal NCV in 2 nerves or abn VPT however both surals and VPT must be recordable

Phase II, 52 weeks, DBPC

Neurology 53:580-591, 1999

Previous slide

Next slide

Back to first slide

View graphic version